{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-22-037955","form_type":"8-K","ticker":"INSM","cik":"0001104506","company_name":"INSMED Inc","filed_at":"2022-10-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:49.623948+00:00","generated_at":"2026-06-23T02:10:48.526377+00:00","sec_items":["8.01","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Insmed raises $775M via term loan, royalty deal, and equity offering to fund pipeline","bullets":["$350M senior secured term loan from Pharmakon Advisors, maturing Oct 2027, at SOFR+7.75% (floor 2.5%).","$150M synthetic royalty deal with OrbiMed: 4-4.5% of ARIKAYCE sales + 0.75% of brensocatib sales, capped at 1.8-1.9x.","$275M equity offering: 13.75M shares at $20.00; closing expected Oct 21, 2022.","Pro forma cash and marketable securities ~$1.3B; proceeds to fund ARIKAYCE commercial launch, brensocatib readiness, and R&D.","Term loan and royalty financing closed Oct 19, 2022; equity underwriting with J.P. Morgan and SVB Securities."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-22-037955","json":"https://secwatch.observer/filing/0001140361-22-037955.json","markdown":"https://secwatch.observer/filing/0001140361-22-037955.md","text":"https://secwatch.observer/filing/0001140361-22-037955.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1104506/000114036122037955/0001140361-22-037955-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1104506/000114036122037955/ny20005570x4_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T02:10:48.526377+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}